CompletedNot Applicable

Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion

66 participantsStarted 2014-06-01

Plain-language summary

This was a single-blind, randomized controlled trial. Sixty-six patients who underwent caudal epidural injection were randomized into the vapocoolant spray group or local infiltration group. Before the insertion of a 20-gauge spinal needle, the subcutaneous tissue was infiltrated with 3 ml of 2% lidocaine in the local infiltration group and vapocoolant spray was applied just before the spinal needle insertion in the spray group. 100-mm visual analog scale to evaluate the pain intensity of spinal needle insertion and a five-point Likert scale for patient satisfaction and preference for repeated use were compared between the two groups.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with low back pain and radiating pain in the lower limb who underwent a scheduled caudal epidural injection Exclusion Criteria: * those who had systemic inflammatory disease, those who take anticoagulant administration, those who had uncontrolled diabetes, those who were unable to understand a visual analog scale (VAS) or a Likert scale, those with a history of cold intolerance or cold allergy, those with a history of allergic reaction to lidocaine, those who took pain medications or had used topical anesthetics within the previous 24 hrs, those who had a skin lesion on the sacral hiatus, and those who had the experience of caudal epidural injection

What they're measuring

100mm visual analog scale

Timeframe: Up to 20 minutes (Just after caudal epidural injection)

Trial details

NCT IDNCT03175913

SponsorThe Catholic University of Korea

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12-01

View on ClinicalTrials.gov More Low Back Pain trials